0K1R.L | Viridian Therapeutics, Inc. Annual & Quarterly

Annual Balance Sheets

(In USD)

Breakdown	2023	2022	2021	2020	2019	2018
Total Assets	490.42 Million	435.09 Million	203.7 Million	131.25 Million	30.26 Million	66.14 Million
Total Current Assets	486.47 Million	424.55 Million	200.16 Million	129.61 Million	29.73 Million	65.37 Million
Cash And Short Term Investments	477.37 Million	424.55 Million	196.96 Million	127.63 Million	26.84 Million	62.48 Million
Cash and Cash Equivalents	102.82 Million	155.57 Million	42.29 Million	45.89 Million	24.84 Million	32.6 Million
Short Term Investments	374.54 Million	268.97 Million	154.66 Million	81.74 Million	1.99 Million	29.87 Million
Net Receivables	102 Thousand	102 Thousand	451 Thousand	-	108 Thousand	24 Thousand
Inventory	-	-6.62 Million	-	-	-	-
Other Current Assets	9 Million	6.52 Million	2.74 Million	1.97 Million	2.78 Million	2.86 Million
Total Non-Current Assets	3.94 Million	10.54 Million	3.54 Million	1.64 Million	523 Thousand	777 Thousand
Net PPE	3.34 Million	2.93 Million	2.05 Million	787 Thousand	523 Thousand	727 Thousand
Good Will And Intangible Assets	-	-	-	-	-	-
Good Will	-	-	-	-	-	-
Intangible Assets	-	-	-	-	-	-
Long-Term Investments	-	-	-	-	-	-
Tax Assets	-	-	-	-	-	-
Other Non Current Assets	604 Thousand	7.6 Million	1.49 Million	857 Thousand	-523 Thousand	50 Thousand
Other Assets	-	-	-	-	-	-
Total Liabilities	48.4 Million	40.02 Million	15.99 Million	11.21 Million	14.5 Million	14.8 Million
Total Current Liabilities	26.63 Million	33.34 Million	13.63 Million	10.67 Million	10.18 Million	6.73 Million
Account Payables	2.23 Million	14.23 Million	2.32 Million	670 Thousand	1.09 Million	571 Thousand
Tax Payables	-	-	-	-	-	-
Short Term Debt	843 Thousand	613 Thousand	520 Thousand	455 Thousand	3.97 Million	2.29 Million
Deferred Revenue	288 Thousand	288 Thousand	289 Thousand	301 Thousand	5 Million	3.78 Million
Other Current Liabilities	23.26 Million	18.21 Million	10.49 Million	9.24 Million	100 Thousand	82 Thousand
Total Non Current Liabilities	21.76 Million	6.67 Million	2.35 Million	544 Thousand	4.32 Million	8.07 Million
Long-Term Debt	20.2 Million	4.64 Million	-	-	4.32 Million	8 Million
Deferred Revenue Non Current	573 Thousand	861 Thousand	1.14 Million	-	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	989 Thousand	1.17 Million	1.2 Million	544 Thousand	-4.32 Million	66 Thousand
Other Liabilities	-	-	-	-	-	-
Total Equity	442.02 Million	395.06 Million	187.71 Million	120.03 Million	15.75 Million	51.34 Million
Stock Holders Equity	442.02 Million	395.06 Million	187.71 Million	120.03 Million	15.75 Million	51.34 Million
Common Stock	540 Thousand	414 Thousand	239 Thousand	42 Thousand	349 Thousand	308 Thousand
Retained Earnings	-725.9 Million	-488.17 Million	-358.3 Million	-278.88 Million	-168.16 Million	-126.29 Million
Accumulated other comprehensive income	338 Thousand	-390 Thousand	-157 Thousand	-8000.00	-	-3000.00
Common Stock Equity	442.02 Million	395.06 Million	187.71 Million	120.03 Million	15.75 Million	51.34 Million
Capital Lease Obligation	843 Thousand	613 Thousand	520 Thousand	455 Thousand	-	-
Total Investments	374.54 Million	268.97 Million	154.66 Million	81.74 Million	1.99 Million	29.87 Million
Total Debt	21.04 Million	5.25 Million	520 Thousand	455 Thousand	8.3 Million	10.29 Million
Net Debt	-81.77 Million	-150.32 Million	-41.77 Million	-45.44 Million	-16.54 Million	-22.3 Million

Breakdown	2024 Q2	2024 Q1	2023 Q4	2023 FY	2023 Q3	2023 Q2
Total Assets	585.66 Million	630.38 Million	490.42 Million	490.42 Million	328.75 Million	351.46 Million
Total Current Assets	581.66 Million	626.81 Million	486.47 Million	486.47 Million	323.83 Million	346.33 Million
Cash And Short Term Investments	571.36 Million	613.18 Million	477.37 Million	477.37 Million	313 Million	334.29 Million
Cash and Cash Equivalents	107.66 Million	91.64 Million	102.82 Million	102.82 Million	111.59 Million	87.08 Million
Short Term Investments	463.69 Million	521.54 Million	374.54 Million	374.54 Million	201.41 Million	247.2 Million
Net Receivables	-	102 Thousand	102 Thousand	102 Thousand	102 Thousand	102 Thousand
Inventory	-	1.00	-	-	-	-
Other Current Assets	10.29 Million	13.52 Million	9 Million	9 Million	10.73 Million	11.93 Million
Total Non-Current Assets	3.99 Million	3.56 Million	3.94 Million	3.94 Million	4.91 Million	5.13 Million
Net PPE	3.34 Million	3 Million	3.34 Million	3.34 Million	3.65 Million	3.95 Million
Good Will And Intangible Assets	-	-	-	-	-	-
Good Will	-	-	-	-	-	-
Intangible Assets	-	-	-	-	-	-
Long-Term Investments	-	-	-	-	-	-
Tax Assets	-	-	-	-	-	-
Other Non Current Assets	659 Thousand	554.99 Thousand	604 Thousand	604 Thousand	1.26 Million	1.18 Million
Other Assets	-	1.00	-	-	-	-
Total Liabilities	56.32 Million	47.85 Million	48.4 Million	48.4 Million	45.18 Million	35.61 Million
Total Current Liabilities	36.76 Million	26.12 Million	26.63 Million	26.63 Million	23.24 Million	28.65 Million
Account Payables	3.14 Million	2.67 Million	2.23 Million	2.23 Million	3.73 Million	4.13 Million
Tax Payables	-	-	-	-	-	-
Short Term Debt	3.47 Million	732 Thousand	843 Thousand	843 Thousand	821 Thousand	802 Thousand
Deferred Revenue	288 Thousand	288 Thousand	288 Thousand	288 Thousand	288 Thousand	288 Thousand
Other Current Liabilities	29.86 Million	22.43 Million	23.26 Million	23.26 Million	18.4 Million	23.43 Million
Total Non Current Liabilities	19.56 Million	21.72 Million	21.76 Million	21.76 Million	21.93 Million	6.95 Million
Long-Term Debt	17.48 Million	20.32 Million	20.2 Million	20.2 Million	20 Million	4.7 Million
Deferred Revenue Non Current	428 Thousand	500 Thousand	573 Thousand	573 Thousand	645 Thousand	717 Thousand
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	1.64 Million	1.39 Million	989 Thousand	989 Thousand	1.28 Million	1.52 Million
Other Liabilities	-	-	-	-	-	-
Total Equity	529.33 Million	582.53 Million	442.02 Million	442.02 Million	283.57 Million	315.85 Million
Stock Holders Equity	529.33 Million	582.53 Million	442.02 Million	442.02 Million	283.57 Million	315.85 Million
Common Stock	639 Thousand	638 Thousand	540 Thousand	540 Thousand	437 Thousand	436 Thousand
Retained Earnings	-839.44 Million	-774.45 Million	-725.9 Million	-725.9 Million	-659.04 Million	-611.38 Million
Accumulated other comprehensive income	-543 Thousand	-367 Thousand	338 Thousand	338 Thousand	-64 Thousand	-173 Thousand
Common Stock Equity	529.33 Million	582.53 Million	442.02 Million	442.02 Million	283.57 Million	315.85 Million
Capital Lease Obligation	507 Thousand	896 Thousand	843 Thousand	843 Thousand	821 Thousand	802 Thousand
Total Investments	463.69 Million	521.54 Million	374.54 Million	374.54 Million	201.41 Million	247.2 Million
Total Debt	20.95 Million	21.95 Million	21.04 Million	21.04 Million	20.82 Million	5.51 Million
Net Debt	-86.7 Million	-69.68 Million	-81.77 Million	-81.77 Million	-90.77 Million	-81.57 Million

Balance Sheet Charts

Suvidhaa Infoserve Limited

SUVIDHAA

Full Analysis

Annual Balance Sheets
Puravankara Limited

PURVA

Full Analysis

Annual Balance Sheets
Nihon M&A Center Holdings Inc.

2127

Full Analysis

Annual Balance Sheets
Yijia Group Corp.

YJGJ

Full Analysis

Annual Balance Sheets
WithSecure Oyj

WITH

Full Analysis

Annual Balance Sheets
FastPartner AB (publ)

FPAR-A

Full Analysis

Annual Balance Sheets

Global Stocks Search

Viridian Therapeutics, Inc. (0K1R.L)

Annual Balance Sheets

Balance Sheet Charts

Suvidhaa Infoserve Limited

Puravankara Limited

Nihon M&A Center Holdings Inc.

Yijia Group Corp.

WithSecure Oyj

FastPartner AB (publ)